NORML.ORG – New Zealand Approves Marijuana Spray As Medicine

Wellington, New Zealand: New Zealand health regulators have approved the sale and marketing of Sativex, an oral spray consisting of natural cannabis extracts (primarily the plant cannabinoids THC and cannabidiol aka CBD) as a treatment for symptoms of multiple sclerosis.

The spray is produced in the United Kingdom and will be exported to New Zealand, where it will be available by prescription.

Sativex has already been approved as a prescription drug in Canada and the United Kingdom and is pending regulatory approval in Spain, France, Germany, and Italy.

For more information, please visit: http://gwpharm.com.

View full post on NORML – Weekly Marijuana News